Strong Outcomes from Propel Sinus Stent Study
Oct 10, 2015
Intersect, the folks behind the new Propel sinus stent, recently presented some findings about the device. The numbers were exceptionally strong across the board, suggesting that implants such as these – and the steroids they use to promote healing – have a positive effect on patient outcomes.
Of the list of presented cases, this section stood out to me:
Keith Matheny, M.D. (Frisco, Texas) presented results of a 20-patient study assessing patient-reported and endoscopic outcomes after placement of the PROPEL steroid releasing implant following sinus surgery during a post-operative office visit. Findings included a statistically significant improvement in patient symptoms observed at four weeks, which were sustained to 12 weeks. Statistically significant reductions were also observed in ethmoid sinus inflammation. The results suggest a therapeutic effect sustained beyond the implant’s biodegradation.
The last part is the meat of the report: not only did Propel confer improvement, but its salutary effects seemed to persist even after removal. This is precisely the sort of value-added benefit we like to see from these devices, particularly since their action only lasts for a few weeks.
To learn more about balloon sinuplasty and the Propel sinus stent, contact the LA sinus surgeons today.